Congenital adrenal hyperplasia: From genetics and biochemistry to clinical practice, part 2

Clinical Pediatrics

Volumn 40, Issue 3, 2001, Pages 125-132

  Collett Solberg, P F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISONE ACETATE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; MINERALOCORTICOID;

ARTICLE; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; EARLY DIAGNOSIS; GENITAL SYSTEM; HORMONE SUBSTITUTION; HUMAN; NEWBORN SCREENING; PRENATAL DIAGNOSIS; STEROIDOGENESIS; SURGICAL APPROACH; TREATMENT PLANNING;

EID: 0035100799     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280104000301     Document Type: Article

References (22)

1. Disorders of sex differentiation
2. Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11beta-hydroxysteroid dehydrogenase reductase activity
3. Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia
4. Home monitoring of 17 hydroxyprogesterone levels in congenital127adrenal hyperplasia with filter paper blood samples [see comments]
5. Correlation of blood-spot 17-hydroxyprogesterone daily profiles and urinary steroidprofiles in congenital adrenal hyperplasia
6. Development of a highly sensitive nonisotopic immunoassay for the determination of salivary 17-hydroxyprogesterone: Reference ranges throughout childhood and adolescence
7. Diagnosis and management of congenital adrenal hyperplasia
8. A preliminary study offlutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia
9. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia
10. The use of adrenalectomy as a treatment for congenital adrenal hyperplasia
11. Pediatric management of ambiguous and traumatized genitalia
12. Congenital adrenal hyperplasia
13. An update on the molecular genetics of congenital adrenal hyperplasia: Diagnostic and therapeutic aspects
14. Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency
15. Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency
16. Prenatal treatment of congenital adrenal hyperplasia
17. Prenatal treatment of congenital adrenal hyperplasia: A promising experimental therapy of unproven safety
18. Prenatal treatment of congenital adrenal hyperplasia: A commentary
19. Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia
20. Congenital adrenal hyperplasia: Update on prenatal diagnosis and treatment
21. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia
22. Molecular diagnosis in the congenital adrenal hyperplasias